Patents Assigned to Seabright Corporation Limited
  • Patent number: 6174550
    Abstract: Methods and compositions for preparation of frozen fermented food products using antifreeze polypeptide-expressing microorganisms are provided. In particular the invention provides for use of fish antifreeze polypeptide-expressing microorganisms in fermentation of milk to produce and store frozen yogurt.
    Type: Grant
    Filed: October 13, 1997
    Date of Patent: January 16, 2001
    Assignees: Seabright Corporation Limited, HSC Research and Development Limited Partnership
    Inventors: Garth L. Fletcher, Choy L. Hew, Shashikant B. Joshi, Yaling Wu
  • Patent number: 5750577
    Abstract: Novel medicinally-useful compounds are provided herein. These compounds include isomeric cyclic tetramers of formaldehyde and 1-naphthol, and the derivatives or analogues of such cyclic tetramers, and linear oligomers of chromotropic acid, or its derivatives or analogues with naphthalene.
    Type: Grant
    Filed: December 5, 1996
    Date of Patent: May 12, 1998
    Assignee: Seabright Corporation Limited
    Inventor: Paris Georghiou
  • Patent number: 5169865
    Abstract: A method, and mediating agents are provided for mediating the physiological effects of hormones, neurotransmitters, calcium-channel antagonists, chemotactic peptides or chemotactic proteins. The mediating agents provided herein are bioactive conformations of peptide hormones, neurotransmitters, calcium-channel antagonist drugs or chemotatic peptides, or analogues, agonists or antagonists thereof, or synthetic analogue substances, having Ca.sup.2+ and/or Mg.sup.2+ ions optimally and optimally-conformationally bound to the respective compound. The Ca.sup.2+ antagonist/agonist may bind Mg.sup.2+ and thus may also block calcium-channel. In the one method, the concentration of intracellular Ca.sup.2+ is raised by means of such mediating agents. A second method is also provided for delivering Ca.sup.2+ and/or Mg.sup.2+ to a membrane-bound receptor by transporting Ca.sup.2+ and/or Mg.sup.2+ through a cell membrane using the above-described mediating agents.
    Type: Grant
    Filed: March 14, 1989
    Date of Patent: December 8, 1992
    Assignee: Seabright Corporation Limited
    Inventor: V. S. Ananthanarayanan